Health Catalyst officer plans sale of 13K shares

Rhea-AI Filing Summary

Health Catalyst, Inc. (HCAT) has a notice of proposed insider sales filed under Rule 144 for shares held by officer Benjamin Landry. The filing states that up to 13,167 shares of common stock may be sold through broker Morgan Stanley Smith Barney LLC, with an aggregate market value reference of $22,431.30 and a stated trading market of NASDAQ. The securities to be sold are described as restricted stock acquired as compensation, with a proposed sale date of September 1, 2026. The filing also lists prior sales over the past three months totaling 13,779 shares of restricted stock for $18,879.99.

Key Figures

Shares to be sold under Rule 144: 13,167 shares of common stock Aggregate market value reference: $22,431.30 Shares sold during past 3 months: 13,779 shares +2 more

5 metrics

Shares to be sold under Rule 144 13,167 shares of common stock Proposed sale of restricted stock with proposed sale date 09/01/2026

Aggregate market value reference $22,431.30 Value associated with 13,167 shares of Health Catalyst, Inc. common stock

Shares sold during past 3 months 13,779 shares Restricted stock sale on 06/01/2026 by Benjamin Landry

Proceeds from past 3 months’ sale $18,879.99 Total consideration for 13,779 shares sold on 06/01/2026

Proposed sale date 09/01/2026 Proposed date for sale of 13,167 restricted shares

Key Terms

Rule 144, Restricted Stock, compensation

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 09/01/2026 | Restricted Stock | Health Catalyst, Inc."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

compensation financial

"13167 | 09/01/2026 | Compensation"

FAQ

What does the Form 144 filing disclose for Health Catalyst, Inc. (HCAT)?

It discloses that officer Benjamin Landry has filed notice under Rule 144 to potentially sell up to 13,167 shares of Health Catalyst, Inc. common stock, identified as restricted stock received as compensation, with a proposed sale date of September 1, 2026.

How many HCAT shares are proposed to be sold under this Form 144?

The notice states a proposed sale of up to 13,167 shares of Health Catalyst, Inc. common stock. These are classified as restricted stock and are associated with a proposed sale date of September 1, 2026.

What is the reference market value of the HCAT shares in the proposed Form 144 sale?

The filing lists an aggregate market value reference of $22,431.30 for the 13,167 shares of Health Catalyst, Inc. common stock to be sold, based on the information included in the securities table.

Which broker is handling the potential Rule 144 sale for HCAT shares?

The proposed sale of Health Catalyst, Inc. common stock is indicated to be through Morgan Stanley Smith Barney LLC, with the broker’s office listed at New York Plaza, New York, in the securities information section.

What prior HCAT stock sales by Benjamin Landry are disclosed in the last 3 months?

The filing reports that 13,779 shares of restricted stock of Health Catalyst, Inc. were sold on June 1, 2026 for total proceeds of $18,879.99, as part of the securities sold during the past three months section.

What type of securities are being sold under this HCAT Form 144 notice?

The securities are described as restricted stock of Health Catalyst, Inc., identified as common stock and noted as having been acquired as compensation in the securities to be sold section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 05:46 PM Accepted by SEC EDGAR 09/01/2026 - 05:46 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001975281
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Health Catalyst, Inc.
SEC File Number	001-38993
Address of Issuer	10897 S River Front Pkwy #300 South Jordan UTAH 84095
Phone	8553096800
Name of Person for Whose Account the Securities are To Be Sold	Benjamin Landry
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	13167	22431.3	75256381	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2026	Restricted Stock	Health Catalyst, Inc.			13167	09/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Landry c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	06/01/2026	13779	18879.99

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Benjamin Landry
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)